5 March 2024 · Antacids, alginates, H2-receptor antagonists or proton pump inhibitors can be used during breastfeeding. Recommendations are for full term and healthy infants.
8 March 2024 · Hyoscine butylbromide, propantheline or peppermint oil are preferred choices during breastfeeding. Recommendations apply to full term and healthy infants.
19 March 2024 · Rectal and anal topical preparations for haemorrhoids and anal fissures are compatible with breastfeeding. Recommendations apply to full term, healthy infants.
26 March 2024 · Some anti-emetics can be used with caution during breastfeeding, depending on the clinical situation. Recommendations apply to full term, healthy infants.
2 May 2024 · Intravenous thiamine for prevention of refeeding syndrome should be reserved for those with intestinal failure where the oral or enteral route is unavailable.
16 July 2024 · Introducing biosimilar ustekinumab needs planning. Work with the multidisciplinary team to ensure familiarity with the area and develop an implementation plan.
2 August 2024 · Ustekinumab biosimilars (Pyzchiva, Steqeyma, Uzpruvo, Wezenla) are licensed. Learn about indications, formulations, supporting evidence and differences.
2 August 2024 · Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring, and pharmacovigilance.
7 November 2024 · This guidance explores the dosing and monitoring advice when using high dose loperamide to reduce high stoma output or in short bowel syndrome in adults.